Showing results (531-540 of 622) with videos related to

Sort By:
Pageof 63
Malaria Journal|November 1, 2018
Prospective comparative multi-centre study on imported Plasmodium ovale wallikeri and Plasmodium ovale curtisi infectionsGerardo Rojo-Marcos, José Miguel Rubio-Muñoz, Andrea Angheben, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2016
First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumJose Manuel Ruiz-Morales, Marcin Swierkowski, J Connor Wells, et al.
Breast (Edinburgh, Scotland)|January 26, 2023
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancerArlene Chan, Manuel Ruiz-Borrego, Gavin Marx, et al.
The Lancet. Oncology|May 21, 2021
Chemotherapy de-escalation using an <sup>18</sup>F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trialJosé Manuel Pérez-García, Geraldine Gebhart, Manuel Ruiz Borrego, et al.
The Lancet. Oncology|October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trialRupert Bartsch, Maximilian Marhold, Javier Garde-Noguera, et al.
Science Advances|July 10, 2026
Periodic shifts in viral load increase risk of Hendra virus spillover from <i>Pteropus</i> batsTamika J Lunn, Benny Borremans, Devin N Jones-Slobodian, et al.
Nature Medicine|May 30, 2025
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trialMatthias Preusser, Javier Garde-Noguera, Juan José García-Mosquera, et al.
Breast Cancer Research and Treatment|December 28, 2017
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)Noam Ponde, Ian Bradbury, Matteo Lambertini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2023
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer PatientsJavier Pascual, Miguel Gil-Gil, Paula Proszek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2023
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast CancerÁngel Guerrero-Zotano, Stefania Belli, Christoph Zielinski, et al.
Pageof 63